Abstract   Background: Hepatitis B virus infection is an important cause of liver morbidity and   mortality worldwide. HDV changes the natural course of HBV. The prevalence of HDV infection wasn’t determined in the various groups of HBV infection (carriers, acute hepatitis, chronic hepatitis, cirrhosis and HCC) in Iran. We aimed to research the prevalence of hepatitis D virus infection in v...

Background: Hepatitis D virus research has advanced in recent decades. In this study, we aim to quantitatively analyze the scientific data field of "hepatitis virus" by using bibliometric analysis.
 Methods: Research documents published Web Science database between 1984 and 2022 were included study. The search keywords D" or "hepatitis-D" "HDV" D." full record cited references extracted co...

there is no report on the etiology of acute viral hepatitis in sistan and baluchestan province, southeast of iran. we performed this study to compare the clinical, biochemical and demographic properties of acute viral hepatitis (avh) in this province. demographic and clinical data were collected from 263 patients with avh. they were tested for hbsag, igm anti-hav, igm anti-hbc, igm anti-hdv, or...

results overall, 3 (15%) subjects achieved svr, 10 cases (50%) relapsed after treatment cessation and 7 (35%) patients did not clear hdv during the treatment. conclusions hdv coinfection with hbv had very low response rate to high doses and long durations of ifn α-2b therapy. objectives we aimed to determine the efficacy of ifn α-2b therapy in patients with hbv/hdv coinfection. patients and met...

background vitamin d deficiency is believed to cause variety of abnormalities such as liver stiffness and fibrosis. it is also shown that vitamin d deficiency may result in chronic liver disease or liver cirrhosis. in this study, we aimed to systematically review the literature wherein the relationship between vitamin d deficiency and the severity of chronic liver disease or liver cirrhosis had...

Background: We explored the effect of vitamin D receptor gene (VDR) polymorphisms in response to PEG-IFN treatment in Egyptian chronic hepatitis B (CHB) patients. Methods: Two hundred hepatitis B virus (HBV) patients (42.3±10.7 years) on PEG-IFN α-2a (180 μg /kg for 48 weeks) and one hundred control subjects (37.3 ±12 years) were enrolled in the study. Vitamin D levels a...